Drug Discount Program: Update on Agency Efforts to Improve 340B Program Oversight
Testimony before the Subcommittee on Oversight and
Investigations, Committee on Energy and Commerce, U.S.
House of Representatives, describing the Health Resources
and Services Administration's (HRSA) actions and plans for
improving 340B program oversight. Also provides an update
on the Government Accountability Office's work regarding
the 340B program and HRSA oversight. Includes information
on 340B program participants, background, structure, audit
frequency, and more.
Government Accountability Office
Medicaid · Pharmacy and prescription drugs · Policy